Showing results (231-240 of 249) with videos related to

Sort By:
Pageof 25
Journal of Virology|October 29, 2010
A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomasShi-Dong Ma, Subramanya Hegde, Ken H Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2016
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros ExpressionRichard J Jones, Tawin Iempridee, Xiaobin Wang, et al.
Mbio|August 22, 2019
Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell CycleMark R Eichelberg, Rene Welch, J Tod Guidry, et al.
Plos Pathogens|June 17, 2020
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized miceChunrong Li, James C Romero-Masters, Shane Huebner, et al.
Plos Pathogens|July 28, 2018
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infectionJillian A Bristol, Reza Djavadian, Emily R Albright, et al.
Journal of Virology|March 6, 2020
An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse ModelJames C Romero-Masters, Makoto Ohashi, Reza Djavadian, et al.
Plos Pathogens|April 26, 2022
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cellsJillian A Bristol, Joshua Brand, Makoto Ohashi, et al.
FEBS Letters|March 23, 2016
Novel autophosphorylation sites of Src family kinases regulate kinase activity and SH2 domain-binding capacityMarion E Weir, Jacqueline E Mann, Thomas Corwin, et al.
The American Journal of Pathology|February 13, 2001
Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterationsM Saghizadeh, D J Brown, R Castellon, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 27, 2024
A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trialNishita Singh, Carol C Kenney, Ken S Butcher, et al.
Pageof 25